WOBURN, MASS. (Aug. 6, 3:15 p.m. ET) — MuCell Extrusion LLC has licensed Dow Chemical Co.'s patent portfolio for thin foamed films.
The deal, announced Aug. 6, adds to the two companies' existing collaboration relationship.
The companies said in a news release that the new agreement “not only eliminates existing confusion among potential customers as to patent and licensing obligations, but it also provides a clear demarcation of responsibilities for support of these foaming technologies.”
Midland, Mich.-based Dow will offer resins specially formulated to optimize foaming results, while Woburn-based MuCell will provide technology transfer equipment and technical support.
This deal follows a similar agreement announced in March for MuCell Extrusion to exclusively license Dow's patent family on flat sheet resin technology.